Assessment of Corneal Endothelial Function Following Hypoxic Stress
NCT ID: NCT04175938
Last Updated: 2025-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1/PHASE2
20 participants
INTERVENTIONAL
2025-12-31
2027-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical Steroids
NCT06913790
One Week Assessment of The Phenacite Lens
NCT02553395
Corneal Thickness Changes With Scleral Contact Lenses
NCT03249233
Contact Lenses and Infiltrative Keratitis
NCT02186431
A Clinical Evaluation of Two Contact Lenses Used With Three Care Systems
NCT04195581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently, there is no method to directly measure how well endothelium cells are functioning in patients with FECD. Such a measurement, if it were possible, would allow physicians to identify patients who are at a higher risk of corneal swelling. The goal of this study is to establish a tool to measure and compare the amounts of corneal swelling between normal and FECD patients after a stress test is performed (the wearing of an FDA-approved contact lens.) Data will also be collected regarding how quickly and how well a cornea recovers from swelling in patients with healthy eyes compared to those with FECD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with Fuch's Endothelial Dystrophy
Persons with a diagnosis of Fuch's Endothelial Dystrophy will wear a contact lens in an affected eye for three hours.
Wearing of contact lens
All subjects will wear a contact lens for three hours. The effect of the lens on the eye (epithelial swelling) will be measured at intervals after the lens is removed.
Subjects with healthy eyes
Persons with healthy eyes will wear a contact lens in one eye for three hours.
Wearing of contact lens
All subjects will wear a contact lens for three hours. The effect of the lens on the eye (epithelial swelling) will be measured at intervals after the lens is removed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wearing of contact lens
All subjects will wear a contact lens for three hours. The effect of the lens on the eye (epithelial swelling) will be measured at intervals after the lens is removed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a clinical diagnosis of Fuchs endothelial corneal dystrophy
* Be scheduled for corneal transplantation in the next 6 months
* Have no history of prior ocular surgery in study eye
* Have no history of contact lens intolerance
* Be motivated and willing to complete ocular imaging tests
Subjects in the healthy eyes arm of the study must meet following criteria:
* Have no prior history of ocular disease including ocular surface disease or glaucoma
* Have no history of prior ocular surgery in study eye
* Have no history of contact lens intolerance
* Be motivated and willing to complete ocular imaging tests
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts Eye and Ear Infirmary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ula Jurkunas
Associate Professor, Harvard Medical School
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ula Jurkunas, MD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts Eye and Ear
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019P002073
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.